Target intelligence / Profile preview

Pre-B-cell leukemia transcription factor 1 (PBX1) (PBX1)

Target
PBX1
Molecular classification
Transcription factor
01

Overview

The Pre-B-cell leukemia transcription factor 1 (PBX1) is a nuclear protein belonging to the Three Aminoacid Loop Extension (TALE) homeodomain-containing family of transcription factors, specifically within the PBC subfamily (PBX1-4), that binds DNA and forms complexes with HOX and other homeobox proteins to regulate target gene expression. It plays crucial roles in embryonic development, including organ patterning, skeletal programming, and early hematopoiesis, where it supports hematopoietic stem cell self-renewal, B-cell and megakaryocyte differentiation, and maintenance of tissue homeostasis. PBX1 isoforms, such as PBX1a (brain/adult), PBX1b (embryonic), and PBX1d (T cells), exhibit tissue-specific expression and functions, including recruitment of chromatin regulators like SWI/SNF complexes. In disease, PBX1 is oncogenic when fused to E2A (TCF3-PBX1 via t(1;19) translocation), accounting for 5-10% of pediatric B-acute lymphoblastic leukemia (B-ALL) by inducing aberrant gene activation, proliferation, and leukemia progression; it is also implicated in solid tumors like breast and ovarian cancer, as well as myeloproliferative neoplasms through overexpression or copy number alterations. Aberrant PBX1 activity disrupts normal differentiation, promotes tumor growth, metastasis, invasion, and drug resistance, highlighting its dual role in development and oncogenesis, though no approved drugs directly target it.

Other names
Pre-B cell leukemia factor 1PBX homeobox family member
02

Biological functions

Organ patterning during embryogenesisHematopoiesisStem cell self-renewal and differentiationSkeletal patterningCell proliferation
03

Disease associations

Cancer (pre-B-cell acute lymphoblastic leukemia, breast cancer, ovarian cancer, myeloproliferative neoplasms, T-acute lymphoblastic leukemia)
04

Safety considerations

Fusion protein E2A-PBX1 (TCF3-PBX1) drives oncogenesis via self-oligomerization and constitutive activation of target genes; associated with therapy resistance in some cancers

Beyond the preview

Go deeper on Pre-B-cell leukemia transcription factor 1 (PBX1) (PBX1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pre-B-cell leukemia transcription factor 1 (PBX1) (PBX1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call